Second Sight Medical Products, Inc. (EYES)

$4.14

-0.22 (-5.05%)
Rating:
Recommendation:
Buy
Symbol EYES
Price $4.14
Beta 2.557
Volume Avg. 0.08M
Market Cap -
Shares () -
52 Week Range 3.42-10.821
1y Target Est -
DCF Unlevered EYES DCF ->
DCF Levered EYES LDCF ->
ROE -13.58% Sell
ROA -13.82% Sell
Operating Margin -
Debt / Equity 4.11% Neutral
P/E -18.40 Strong Sell
P/B 0.86 Buy
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest EYES news


Mr. Matthew Pfeffer
Healthcare
Medical Devices
NASDAQ Capital Market

As of August 30, 2022, Second Sight Medical Products, Inc. was acquired by Nano Precision Medical, Inc., in a reverse merger transaction. Second Sight Medical Products, Inc. develops, manufactures, and markets implantable visual prosthetics that are intended to deliver artificial vision to blind individuals. It develops technologies to treat the population of sight-impaired individuals. The company offers the Orion Visual Cortical Prosthesis System, an implanted cortical stimulation device, which is intended to provide useful artificial vision to individuals who are blind due to various causes, including glaucoma, diabetic retinopathy, optic nerve injury or disease, and eye injury. The company was founded in 1998 and is headquartered in Sylmar, California.